VCYT

NASDAQ · Biotechnology

Veracyte Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$40.42

-0.34 (-0.83%)

As of May 9, 9:35 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 15 79%

Hold 3 16%

Sell 1 5%

Price Target

Analyst Price Target +15.9% upside

Low Target $30.44

Average Target $46.85

High Target $57.64

Current Price $40.42

Current
$40.42

Target
$46.85

$30.44 $46.85 avg $57.64

Scenario Analysis

Bear Case

$30.44

-24.7%

Low target

Base Case

$46.85

+15.9%

Avg target

Bull Case

$57.64

+42.6%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$50.71

-20.3% from high

52-Week Low

$22.61

+78.8% from low

50-Day SMA

$40.85

-1.1% vs SMA

200-Day SMA

$34.09

+18.6% vs SMA

RSI (14)

37.6

Neutral

Target vs 52W High

$46.85

-7.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	72%	$257.58	+27.8%
AMGN Amgen Inc	Hold	43	49%	$190.87	-42.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+176.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-19.5%
INSM Insmed Inc	Strong Buy	26	96%	$143.40	+41.5%